blood cancer
Harnessing the Potential of CAR T-Cell Therapy for Multiple Myeloma
Multiple myeloma, a blood cancer that develops in plasma cells, can result in low blood counts and weakening of the ...
DECEMBER 15, 2024
FDA Grants Pemazyre a New Indication for Myeloid/Lymphoid Neoplasms
The FDA granted a new indication for Pemazyre to treat adults with relapsed or refractory myeloid/lymphoid ...
AUGUST 30, 2022
FDA Approves First Treatment for Erdheim-Chester Disease
The first FDA-approved treatment for ECD, Zelboraf is indicated to treat patients whose cancer cells have ...
NOVEMBER 6, 2017
Load more